FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely oncology, and can be used for pre-operative diagnosis of synchronous lymphatic metastasis in non-small-cell lung cancer patients (NSCLC). Method involves detecting leukocyte and thrombocyte levels in peripheral blood, fibrinogen concentration, C-reactive protein and cortisol. Probability of lymphatic metastasis is calculated from the value of the regression equation. At probability P ≥ 50 % define a high risk of having lymphogenic metastases, while a probability of P < 50 % shows a low risk of having lymphogenic metastases.
EFFECT: using the invention enables providing more accurate and informative diagnostics of the preoperative assessment of synchronous lymphatic metastases of NSCLC for selecting the most optimal therapeutic approach.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR THE SYNCHRONOUS LYMPHATIC METASTASIS PREDICTION IN THE PATIENTS WITH NON-SMALL CELL LUNG CANCER FOLLOWING THE NEOADJUVANT CHEMOTHERAPY | 2020 |
|
RU2740850C1 |
| METHOD FOR PREDICTION OF LYMPHATIC CANCER SPREAD ACCOMPANIED BY INVASIVE NONSPECIFIC TRIPLE-NEGATIVE BREAST CANCER | 2014 |
|
RU2558860C1 |
| METHOD FOR PREDICTING LYMPHATIC CANCER SPREAD IN PANCREATIC DUCTUAL ADENOCARCINOMA | 2017 |
|
RU2648442C1 |
| METHOD FOR PREDICTION OF LYMPHATIC METASTASIS IN COLON ADENOCARCINOMA | 2019 |
|
RU2688678C1 |
| WAY OF FORECASTING OF DEGREE OF LYMPHOGENOUS INNIDIATION AT INFILTRATIVE DUCTAL MAMMARY GLAND CANCER | 2008 |
|
RU2362996C1 |
| METHOD FOR PREOPERATIVE PREDICTION OF THE RISK OF LYMPHATIC METASTASIS IN PATIENTS WITH ENDOMETRIAL CANCER T1 INTERMEDIATE RISK STAGE WITH METABOLIC SYNDROME | 2020 |
|
RU2737130C1 |
| METHOD OF PREDICTING HIGH RISK OF REGIONAL METASTASIS IN BREAST CANCER | 2023 |
|
RU2816441C1 |
| METHOD OF PREDICTING NODAL METASTASIS IN TWO-WAY SYNCHRONOUS INVASIVE CARCINOMA OF NON-SPECIFIC TYPE OF MAMMARY GLANDS | 2015 |
|
RU2578462C1 |
| METHOD OF PREDICTING HEMATOGENOUS METASTASIS IN INVASIVE CARCINOMA OF NONSPECIFIC TYPE OF MAMMARY GLAND BASED ON DETERMINATION OF DIFFERENT POPULATIONS OF CIRCULATING TUMOR CELLS IN BLOOD BEFORE TREATMENT | 2018 |
|
RU2678202C1 |
| METHOD FOR PREDICTING LYMPHOGENOUS METASTASIS IN INVASIVE CARCINOMA OF NONSPECIFIC TYPE OF MAMMARY GLAND | 2016 |
|
RU2659938C2 |
